SCHEMBL6488207

SCHEMBL6488207

CC(C)COC(=O)c1cn[nH]c1-c1cc2ccccc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 3/20 0.49
TSHR P16473 2/20 0.47
ITK Q08881 3/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
GSK3B P49841 1/20 0.44
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
BRD4 O60885 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
SYK P43405 4/20 0.38
SLC22A12 Q96S37 1/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756183 0.87 ALDH1A1 (0.48) ALDH1A1KDM4ETSHRITKLMNA
SCHEMBL6489610 0.85 KDM4E (0.48) ALDH1A1KDM4ETSHRITKCCNE1
SCHEMBL6478196 0.85 KDM4E (0.55) ALDH1A1KDM4EITKCCNE1CDK2
SCHEMBL5755243 0.83 ITK (0.46) ALDH1A1KDM4ETSHRITKTP53
SCHEMBL6478111 0.83 ALDH1A1 (0.50) ALDH1A1KDM4ETSHRITKTP53
SCHEMBL5755157 0.81 DCAF1 (0.45) ITKCCNE1CDK2GSK3BBRD4
SCHEMBL5753389 0.80 ITK (0.44) ITKCCNE1CDK2GSK3BLMNA
SCHEMBL5756205 0.78 KDM4E (0.47) KDM4EITKCCNE1CDK2GSK3B
SCHEMBL5754202 0.77 CHEK1 (0.46) KDM4EITKGSK3BBRD4SYK
SCHEMBL5756905 0.76 BRD4 (0.45) ALDH1A1KDM4ETSHRITKCCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 ALDH1A1 2469/4885KDM4E 765/4885TSHR 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.